
Gastroenterologist

No OPD information available
Colitis
Crohn's Disease
Hemorrhagic Proctocolitis
Ulcerative Colitis
Viral Gastroenteritis
Menetrier Disease
Campylobacter Infection
Colonoscopy
Colostomy
Endoscopy
Gastrointestinal Fistula
Ileostomy
Necrosis
Proctitis
Pseudomembranous Colitis
Shingles
Susan J. Connor is a female medical professional who helps people with different stomach and intestine problems like Colitis, Crohn's Disease, and Ulcerative Colitis. She also treats infections like Campylobacter and conditions like Shingles. Susan is skilled in procedures like Colonoscopy and Endoscopy, and she can perform surgeries like Colostomy and Ileostomy when needed.
Susan talks to her patients in a friendly and clear way, making sure they understand their conditions and treatments. Patients trust her because she listens carefully to their concerns and explains things in a simple manner. She stays updated with the latest medical knowledge by reading new research and attending conferences to learn from other experts.
Susan works well with other medical professionals, sharing her knowledge and collaborating on patient care. She values teamwork and respects her colleagues' opinions, which helps her provide the best care for her patients. Susan's approach to medicine is compassionate and patient-centered, always putting her patients' well-being first.
One of Susan's notable works is a study on improving the treatment of Crohn's perianal fistulas, which has helped many patients heal better. She has also been involved in a clinical trial for a new treatment for Ulcerative Colitis and Crohn's Disease, showing her commitment to finding better solutions for her patients.
Overall, Susan J. Connor is a dedicated and caring medical professional who uses her skills and knowledge to make a positive impact on her patients' lives. Through her expertise, communication skills, and commitment to learning, she continues to provide high-quality care to those in need.
Enrollment Status: Completed
Published: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
